111 (NASDAQ:YI) Stock Price Down 6.4%

111, Inc. (NASDAQ:YI) traded down 6.4% during trading on Tuesday . The stock traded as low as $15.23 and last traded at $18.70. 1,364,058 shares changed hands during trading, a decline of 7% from the average session volume of 1,472,516 shares. The stock had previously closed at $19.98.

The stock has a market cap of $1.54 billion, a price-to-earnings ratio of -20.27 and a beta of 1.21. The company has a 50 day simple moving average of $12.82 and a 200 day simple moving average of $8.13.

Hedge funds and other institutional investors have recently modified their holdings of the business. Credit Suisse AG raised its stake in 111 by 111.6% during the fourth quarter. Credit Suisse AG now owns 22,180 shares of the company’s stock worth $154,000 after acquiring an additional 11,700 shares in the last quarter. State Street Corp increased its stake in shares of 111 by 45.2% in the third quarter. State Street Corp now owns 48,216 shares of the company’s stock valued at $299,000 after buying an additional 15,016 shares during the period. BlackRock Inc. increased its stake in shares of 111 by 6.5% in the third quarter. BlackRock Inc. now owns 206,544 shares of the company’s stock valued at $1,281,000 after buying an additional 12,580 shares during the period. Renaissance Technologies LLC increased its stake in shares of 111 by 67.1% in the fourth quarter. Renaissance Technologies LLC now owns 290,939 shares of the company’s stock valued at $2,022,000 after buying an additional 116,842 shares during the period. Finally, Artal Group S.A. increased its stake in shares of 111 by 53.8% in the fourth quarter. Artal Group S.A. now owns 1,000,000 shares of the company’s stock valued at $6,950,000 after buying an additional 350,000 shares during the period. 3.82% of the stock is owned by hedge funds and other institutional investors.

111 Company Profile (NASDAQ:YI)

111, Inc, through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers.

Further Reading: Trading on Margin

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.